HCA
CVS icon

Horan Capital Advisors’s CVS Health CVS Stock Holding History

Horan Capital Advisors’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-30,663
Closed -$1.38M – 120
2024
Q4 		$1.38M Sell
30,663
-7,644
-20% -$429K 0.46% 54
2024
Q3 		$2.41M Sell
38,307
-395
-1% -$23K 0.8% 46
2024
Q2 		$2.29M Sell
38,702
-373
-1% -$23.3K 0.8% 46
2024
Q1 		$3.12M Buy
39,075
+40
+0.1% +$3.06K 1.11% 34
2023
Q4 		$3.08M Sell
39,035
-1,109
-3% -$78.9K 1.13% 32
2023
Q3 		$2.8M Sell
40,144
-1,813
-4% -$128K 1.13% 34
2023
Q2 		$2.9M Buy
41,957
+665
+2% +$47.3K 1.13% 31
2023
Q1 		$3.07M Buy
41,292
+732
+2% +$61.4K 1.26% 30
2022
Q4 		$3.78M Sell
40,560
-11
-0% -$1.06K 1.66% 21
2022
Q3 		$3.87M Buy
40,571
+805
+2% +$79.7K 1.87% 12
2022
Q2 		$3.69M Sell
39,766
-13,382
-25% -$1.31M 1.71% 14
2022
Q1 		$5.38M Buy
53,148
+539
+1% +$56.6K 2.16% 8
2021
Q4 		$5.43M Buy
52,609
+112
+0.2% +$10.3K 2.15% 8
2021
Q3 		$4.46M Buy
52,497
+879
+2% +$73.6K 1.97% 10
2021
Q2 		$4.31M Buy
51,618
+1,671
+3% +$137K 1.94% 13
2021
Q1 		$3.76M Buy
49,947
+163
+0.3% +$11.9K 1.8% 14
2020
Q4 		$3.4M Buy
49,784
+2,275
+5% +$148K 1.76% 18
2020
Q3 		$2.77M Buy
47,509
+546
+1% +$34K 1.57% 20
2020
Q2 		$3.05M Sell
46,963
-150
-0.3% -$9.45K 2.05% 14
2020
Q1 		$2.79M Buy
47,113
+1,832
+4% +$122K 2.23% 12
2019
Q4 		$3.36M Sell
45,281
-751
-2% -$52.7K 2% 11
2019
Q3 		$2.9M Buy
46,032
+40
+0.1% +$2.37K 1.77% 15
2019
Q2 		$2.51M Buy
45,992
+15,009
+48% +$808K 1.69% 22
2019
Q1 		$1.67M Sell
30,983
-2,288
-7% -$141K 1.06% 42
2018
Q4 		$2.18M Buy
33,271
+1,567
+5% +$117K 1.46% 36
2018
Q3 		$2.5M Sell
31,704
-438
-1% -$31.3K 1.61% 29
2018
Q2 		$2.07M Buy
32,142
+210
+0.7% +$13.8K 1.33% 37
2018
Q1 		$1.99M Buy
31,932
+1,485
+5% +$107K 1.3% 38
2017
Q4 		$2.21M Sell
30,447
-1,565
-5% -$114K 1.44% 35
2017
Q3 		$2.6M Sell
32,012
-103
-0.3% -$8.15K 1.6% 28
2017
Q2 		$2.58M Buy
32,115
+1,000
+3% +$79K 1.76% 22
2017
Q1 		$2.44M Buy
31,115
+1,905
+7% +$152K 1.74% 24
2016
Q4 		$2.31M Buy
29,210
+225
+0.8% +$18.2K 1.72% 28
2016
Q3 		$2.58M Buy
28,985
+640
+2% +$60.4K 2.05% 16
2016
Q2 		$2.71M Buy
28,345
+295
+1% +$29.4K 2.21% 12
2016
Q1 		$2.91M Buy
28,050
+853
+3% +$82.9K 2.26% 9
2015
Q4 		$2.66M Sell
27,197
-1,063
-4% -$104K 2.22% 13
2015
Q3 		$2.73M Buy
28,260
+1,465
+5% +$154K 2.29% 8
2015
Q2 		$2.81M Buy
26,795
+895
+3% +$91.4K 2.37% 12
2015
Q1 		$2.67M Buy
25,900
+985
+4% +$99.7K 2.23% 13
2014
Q4 		$2.31M Sell
24,915
-6,473
-21% -$570K 1.91% 19
2014
Q3 		$2.5M Buy
31,388
+3,763
+14% +$297K 2.21% 12
2014
Q2 		$2.08M Buy
27,625
+1,915
+7% +$145K 1.9% 19
2014
Q1 		$1.93M Buy
25,710
+1,460
+6% +$103K 1.85% 18
2013
Q4 		$1.74M Buy
24,250
+1,200
+5% +$77.1K 1.77% 16
2013
Q3 		$1.31M Buy
23,050
+2,690
+13% +$160K 1.56% 24
2013
Q2 		$1.16M Buy
+20,360
New +$1.18M 1.77% 23

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Horan Capital Advisors's CVS Position: Q1 2025 in Review

Horan Capital Advisors sold out of CVS Health (CVS) in Q1 2025, closing a stake of 30,663 shares — an estimated $1.38M sold.

Horan Capital Advisors first reported a position in CVS in Q2 2013 and held it in 47 quarters. The position peaked at $5.43M in Q4 2021. 1,754 funds tracked by Wall St. Rank hold CVS as of Q1 2025.

  • Horan Capital Advisors reported no remaining CVS Health position as of Q1 2025 after selling out during the quarter.
  • Horan Capital Advisors sold 30,663 CVS Health shares in Q1 2025, an estimated $1.38M.
  • Horan Capital Advisors first reported a position in CVS Health in Q2 2013 and held it in 47 quarters.
  • Horan Capital Advisors's CVS Health position peaked at $5.43M in Q4 2021.
  • 1,754 funds tracked by Wall St. Rank held CVS Health as of Q1 2025.

Based on Horan Capital Advisors's 13F filing for Q1 2025, filed 7 May 2025.